Jianyang Xiang

644 total citations
16 papers, 514 citations indexed

About

Jianyang Xiang is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Jianyang Xiang has authored 16 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Jianyang Xiang's work include Glioma Diagnosis and Treatment (11 papers), Ferroptosis and cancer prognosis (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Jianyang Xiang is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Ferroptosis and cancer prognosis (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Jianyang Xiang collaborates with scholars based in China, Sweden and Italy. Jianyang Xiang's co-authors include Jionghuang Chen, Liping Cao, Guoping Ding, Guixing Jiang, Liangjing Zhou, Jian Chen, Zhengrong Wu, Wei Wu, Alafate Wahafu and Wanfu Xie and has published in prestigious journals such as Experimental Cell Research, Cell Death and Disease and Oncotarget.

In The Last Decade

Jianyang Xiang

16 papers receiving 509 citations

Peers

Countries citing papers authored by Jianyang Xiang

Since Specialization

Citations

This map shows the geographic impact of Jianyang Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianyang Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianyang Xiang more than expected).

Fields of papers citing papers by Jianyang Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianyang Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianyang Xiang. The network helps show where Jianyang Xiang may publish in the future.

Co-authorship network of co-authors of Jianyang Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianyang Xiang. A scholar is included among the top collaborators of Jianyang Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianyang Xiang. Jianyang Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Development of prognostic indicator based on NAD+ metabolism related genes in glioma 2023 ·Frontiers in Surgery ·Xiaohong Chen, Wei Wu, Yichang Wang, Beichen Zhang, Haoyu Zhou, Jianyang Xiang, Xiaodong Li, Hai Yu, Xiaobin Bai, Wanfu Xie, (unknown), Maode Wang, Jia Wang	3
2	CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway 2022 ·Experimental Cell Research ·Yichang Wang, Gang Bao, Miao Zhang, Jianyang Xiang, Haoyu Zhou, Alafate Wahafu, Wei Wu, Xudong Ma, (unknown), Xiaobin Bai, Wanfu Xie, Peijun Liu, Maode Wang	7
3	NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway 2022 ·Cell Death and Disease ·Jianyang Xiang, Alafate Wahafu, Wei Wu, Yichang Wang, Xiao-Dong Li, Wanfu Xie, Xiaobin Bai, Ruichun Li, (unknown), Jia Wang	20
4	A Novel Risk Score Model Based on Eleven Extracellular Matrix-Related Genes for Predicting Overall Survival of Glioma Patients 2022 ·Journal of Oncology ·Xiaodong Li, Yichang Wang, Wei Wu, Jianyang Xiang, Lei Qi, Ning Wang, (unknown), Hai Yu	4
5	A novel DNA damage and repair‐related gene signature to improve predictive capacity of overall survival for patients with gliomas 2022 ·Journal of Cellular and Molecular Medicine ·(unknown), Yichang Wang, Wei Wu, Jianyang Xiang, Maode Wang, Hai Yu	6
6	A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients 2022 ·Frontiers in Oncology ·Wei Wu, Yichang Wang, Jianyang Xiang, Xiaodong Li, Alafate Wahafu, Xiao Yu, Xiaobin Bai, (unknown), Chunbao Wang, Ning Wang, (unknown), Wanfu Xie, Maode Wang, Jia Wang	3
7	FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signaling 2021 ·Journal of Cellular and Molecular Medicine ·Yichang Wang, Alafate Wahafu, Wei Wu, Jianyang Xiang, (unknown), Xudong Ma, (unknown), Hao Liu, Xiaobin Bai, (unknown), Wanfu Xie, Maode Wang, Jia Wang	24
8	Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas 2021 ·Cancer Science ·Wei Wu, Yichang Wang, Chen Niu, Alafate Wahafu, (unknown), Xiaoye Guo, Jianyang Xiang, Xiaodong Li, Wanfu Xie, Xiaobin Bai, Maode Wang, Jia Wang	7
9	Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling 2020 ·Journal of Experimental & Clinical Cancer Research ·Alafate Wahafu, (unknown), Wei Wu, Jianyang Xiang, Xudong Ma, Wanfu Xie, Xiaobin Bai, Maode Wang, Jia Wang	22
10	Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients 2020 ·Frontiers in Oncology ·Wei Wu, (unknown), Alafate Wahafu, Yichang Wang, Jianyang Xiang, Lizhe Zhu, Bolin Li, Maode Wang, Jia Wang	8
11	Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma 2020 ·CNS Neuroscience & Therapeutics ·Alafate Wahafu, Xiaodong Li, Jie Zuo, Hua Zhang, Jianyang Xiang, Wei Wu, Wanfu Xie, Xiaobin Bai, Maode Wang, Jia Wang	50
12	Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin 2016 ·Journal of Zhejiang University SCIENCE B ·Jionghuang Chen, Jianyang Xiang, Guoping Ding, Liping Cao	29
13	Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p 2015 ·Oncotarget ·Guoping Ding, Liangjing Zhou, (unknown), (unknown), Jian Chen, Jionghuang Chen, Jianyang Xiang, Zhengrong Wu, Guixing Jiang, Liping Cao	247
14	A Novel Spider Peptide Toxin Suppresses Tumor Growth Through Dual Signaling Pathways 2012 ·Current Molecular Medicine ·(unknown), Mi Deng, Jianyang Xiang, (unknown), (unknown), (unknown), (unknown), S. Liang	59
15	Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors 2012 ·Oncology Letters ·J. Carlsson, Li Shen, Jianyang Xiang, (unknown), Qichun Wei	21
16	Correlation of preS antigens and clinical status during chronic hepatitis B virus infection 1991 ·Medical Microbiology and Immunology ·Gloria Taliani, (unknown), Daniela Francisci, Jianyang Xiang, (unknown), C. De Bac, Giuliano Stagni	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact